Aras co-founded Avicanna with the vision of establishing an international bio-pharmaceutical company with a strict focus on medical and pharmaceutical applications of naturally derived medicines including cannabinoids. His experience in the biotechnology and management consulting have been integral to Avicanna’s thought leadership and progress pertaining to R&D and clinical development of cannabinoid-based products and the ultimate commercialization of the company’s extensive pipeline of proprietary products. Since 2016 Aras has successfully led a team of executives and scientists to navigate the complex, emerging and regulated cannabis industry across several international markets with focus on scientific vigor and evidence-based approach to products. Aras holds a Bachelor of Economics degree from York University and an International master’s in management degree from EADA Business School in Barcelona, Spain.
